NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
10.6x
Industry median - 4.4x
5Y Historical average - 8.9x
(2.0x)
Industry median - 1.0x
5Y Historical average - 2.5x
FCF to Interest
99.8x
Industry median - (28.7x)
5Y Historical average - (212.0x)
2.0%
Industry median - 3.9%
5Y Historical average - 4.5%
PTGX Health Rating
Crunching data... Almost there!
PTGX Financial Stability & Strength
Crunching data... Almost there!
Competing with PTGX Financial Health
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) quick ratio?
The Protagonist Therapeutics, Inc. (PTGX) quick ratio is 10.6x, compared to the industry median of 4.4x and the 5-year historical average of 8.9x.
What is the Protagonist Therapeutics, Inc. (PTGX) net debt to Free Cash Flow (FCF) ratio?
The Protagonist Therapeutics, Inc. (PTGX) net debt to FCF ratio is (2.0x), compared to the industry median of 1.0x and the 5-year historical average of (2.5x).
What is Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow (FCF) to interest ratio?
Protagonist Therapeutics, Inc. (PTGX) FCF to interest ratio is 99.8x, compared to the industry median of (28.7x) and the 5-year historical average of (212.0x).
What is the Protagonist Therapeutics, Inc. (PTGX) total debt to equity ratio?
The Protagonist Therapeutics, Inc. (PTGX) total debt to equity ratio is 2.0%, compared to the industry median of 3.9% and the 5-year historical average of 4.5%.